14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 WINT stock ended at $4.40. This is 9.74% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 39.50% from a day low at $4.38 to a day high of $6.11.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Windtree Therapeutics Inc prices

Date Open High Low Close Volume
Nov 21, 2016 $1.62 $1.65 $1.50 $1.55 93 123
Nov 18, 2016 $1.62 $1.66 $1.60 $1.62 46 846
Nov 17, 2016 $1.66 $1.68 $1.60 $1.64 33 710
Nov 16, 2016 $1.65 $1.70 $1.62 $1.67 83 878
Nov 15, 2016 $1.72 $1.76 $1.61 $1.71 187 799
Nov 14, 2016 $1.80 $1.90 $1.75 $1.79 82 361
Nov 11, 2016 $1.72 $2.00 $1.66 $1.85 325 436
Nov 10, 2016 $1.65 $1.68 $1.58 $1.66 173 166
Nov 09, 2016 $1.65 $1.72 $1.57 $1.65 136 165
Nov 08, 2016 $1.63 $1.73 $1.55 $1.64 102 491
Nov 07, 2016 $1.57 $1.66 $1.57 $1.62 32 700
Nov 04, 2016 $1.67 $1.67 $1.49 $1.57 98 300
Nov 03, 2016 $1.68 $1.69 $1.44 $1.44 92 900
Nov 02, 2016 $1.85 $1.86 $1.65 $1.70 83 900
Nov 01, 2016 $1.85 $1.94 $1.71 $1.74 117 100
Oct 31, 2016 $2.02 $2.06 $1.76 $1.82 209 200
Oct 28, 2016 $2.15 $2.15 $2.00 $2.05 184 900
Oct 27, 2016 $2.31 $2.43 $2.08 $2.22 449 400
Oct 26, 2016 $2.40 $2.43 $2.02 $2.20 272 900
Oct 25, 2016 $3.50 $3.50 $2.28 $2.42 525 700
Oct 24, 2016 $2.84 $3.30 $2.80 $3.24 359 600
Oct 21, 2016 $2.53 $2.89 $2.47 $2.85 132 600
Oct 20, 2016 $2.56 $2.56 $2.40 $2.48 18 400
Oct 19, 2016 $2.41 $2.50 $2.40 $2.43 33 200
Oct 18, 2016 $2.52 $2.53 $2.31 $2.45 25 400
Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF,... WINT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT